Anteris Technologies Ltd. announced the appointment of Dr. Chris Meduri MD MPH, as its Chief Medical Officer (CMO). Dr. Meduri is a recognized leader in the field of valvular heart disease, serving as the national principle investigator of several valve trials and on numerous steering committees. He has performed first-in-US and first-in-world procedures, led enrollment in many trials and actively participated in 11 transcatheter early feasibility studies.